Noroclav 50mg Tablets are indicated for treatment of the following infections caused by beta-lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid:
'Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci.
'Urinary tract infections caused by susceptible Staphylococci or Escherichia coli.
'Respiratory infections caused by susceptible Staphylococci.
'Enteritis caused by susceptible Escherichia coli.
It is recommended to carry out suitable tests for sensitivity testing when initiating the treatment. The treatment should only proceed if sensitivity is proven to the combination.
In vitro potentiated amoxicillin is active against a wide range of clinically important aerobic and anaerobic bacteria including:
Staphylococci (including beta-lactamase producing strains)
Escherichia coli (including most beta-lactamase producing strains)